Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-27

Clinical Trial Update: Kratom Use Disorder Management Using Clonidine and/or Buprenorphine

View source ↗

Summary

A clinical trial is evaluating whether clonidine and/or buprenorphine can help manage withdrawal symptoms in kratom use disorder, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Salem Anaesthesia Pain Clinic | Conditions: Withdrawal Syndrome | Status: RECRUITING